A:TACE+sorafenib

2 trials

Sponsors

Henan cancer hospital, Henan Cancer hospital

Conditions

Intermediate hepatocellular carcinomahepatocellular carcinoma with portal vein tumor thrombosis

Unknown Phase

A prospective, multi-center comparison study of transarterial chemoembolization combined with sorafenib and transarterial chemoembolization combined with 125I seed implantation for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis

Active, not recruitingChiCTR-ONN-16007929

Henan Cancer hospitalhepatocellular carcinoma with portal vein tumor thrombosis

Start: 2016-03-01Updated: 2017-04-18

TACE plus sorafenib VS TACE monotherapy for the treatment of Multi-nodular hepatocellular carcinoma (Stage BCLC B): A prospective, multi-center comparison study

Active, not recruitingChiCTR-ONN-16007928

Henan cancer hospitalIntermediate hepatocellular carcinoma

Start: 2016-03-01Updated: 2017-04-18

Related Papers

Hepatocellular Carcinoma With Portal Vein Tumor Thrombus Treated With Transarterial Chemoembolization and Sorafenib vs.125Iodine Implantation

Frontiers in Oncology2021-12-2326 citations